New phenothiazine-type multidrug resistance modifiers:: anti-MDR activity versus membrane perturbing potency

被引:36
作者
Hendrich, AB
Wesolowska, O
Motohashi, N
Molnár, J
Michalak, K
机构
[1] Wroclaw Med Univ, Dept Biophys, PL-50368 Wroclaw, Poland
[2] Meiji Pharmaceut Univ, Dept Med Chem, Kiyose, Tokyo 2048588, Japan
[3] Albert Szent Gyorgvi Med Univ, Inst Microbiol, H-6720 Szeged, Hungary
关键词
phenothiazine derivatives; multidrug resistance reversal; drug-lipid interactions; lipid bilayer fluidity; P-glycoprotein;
D O I
10.1016/S0006-291X(03)00580-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The phenothiazine multidrug resistance (MDR) modulators are chemically diversified but share the common feature to be hydrophobic cationic molecules. Molecular mechanisms of their action may involve interactions with either P-glycoprotein or Membrane lipid matrix. In the present work we study the anti-MDR and biophysical membrane effects of new phenothiazine derivatives differing in the type of group substituting phenothiazine ring at position 2 (H-, CI-, CF3-) and in the side chain group (NHCO2CH3 or NHSO2CH3). Within each phenothiazine subset we found that anti-MDR activity (determined by P-glycoprotein inhibition assessed by flow cytometry) correlates with the theoretically calculated hydrophobicity value (log P) and experimental parameters (determined by calorimetry and fluorescence spectroscopy) of lipid bilayers. It is concluded that the biological and biophysical activity of phenothiazine derivatives depends more on the type of ring substitution than on the nature of the side chain group. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:260 / 265
页数:6
相关论文
共 40 条
[1]   Characterization of functional assays of multidrug resistance P-glycoprotein transport activity [J].
Bosch, I ;
Crankshaw, CL ;
PiwnicaWorms, D ;
Croop, JM .
LEUKEMIA, 1997, 11 (07) :1131-1137
[2]   P-glycoprotein multidrug resistance and cancer [J].
Bosch, I ;
Croop, J .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1288 (02) :F37-F54
[3]   Membrane permeation by multidrug-resistance-modulators and non-modulators: Effects of hydrophobicity and electric charge [J].
Castaing, M ;
Brouant, P ;
Loiseau, A ;
Santelli-Rouvier, C ;
Santelli, M ;
Alibert-Franco, S ;
Mahamoud, A ;
Barbe, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (03) :289-296
[4]  
Ecker G, 1999, MOL PHARMACOL, V56, P791
[5]   The role of passive transbilayer drug movement in multidrug resistance and its modulation [J].
Eytan, GD ;
Regev, R ;
Oren, G ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12897-12902
[6]   Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane [J].
Ferté, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (02) :277-294
[7]  
FORD JM, 1989, MOL PHARMACOL, V35, P105
[8]   CALORIMETRIC, C-13 NMR, AND P-31 NMR-STUDIES ON INTERACTION OF SOME PHENOTHIAZINE DERIVATIVES WITH DIPALMITOYL PHOSPHATIDYLCHOLINE MODEL MEMBRANES [J].
FRENZEL, J ;
ARNOLD, K ;
NUHN, P .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 507 (02) :185-197
[9]   ATOMIC PHYSICOCHEMICAL PARAMETERS FOR 3-DIMENSIONAL STRUCTURE DIRECTED QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS .3. MODELING HYDROPHOBIC INTERACTIONS [J].
GHOSE, AK ;
PRITCHETT, A ;
CRIPPEN, GM .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1988, 9 (01) :80-90
[10]   INFLUENCE OF CATIONIC AMPHIPHILIC DRUGS ON THE PHASE-TRANSITION TEMPERATURE OF PHOSPHOLIPIDS WITH DIFFERENT POLAR HEADGROUPS [J].
HANPFT, R ;
MOHR, K .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 814 (01) :156-162